Cholera (Vibrio cholerae)

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Cholera spreads when people ingest food or water contaminated with toxin-producing Vibrio cholerae. Many infections cause few or no symptoms. In severe illness, sudden watery diarrhea and vomiting can cause life-threatening fluid loss within hours. Prompt replacement of water and salts is lifesaving.

Clinical Definition

Epidemic cholera is a small-intestinal infection caused by toxigenic Vibrio cholerae O1 or O139. The toxin drives chloride and water secretion without invading the mucosa. Most infections are asymptomatic or mild, but profuse rice-water stools can rapidly cause dehydration and hypovolemic shock. Glucose-coupled sodium absorption persists, which is why oral rehydration solution works even while diarrhea continues.

Inciting Event

  • Ingestion of water or food contaminated with toxigenic Vibrio cholerae is the inciting event.

  • Exposure often occurs during floods or natural disasters disrupting water sanitation.

  • Consumption of raw or undercooked seafood from contaminated sources can trigger infection.

Latency Period

  • Symptoms generally begin 12 hours to 5 days after ingestion.

  • Many exposed people remain asymptomatic. In severe illness, major fluid losses can occur within hours after diarrhea starts.

Diagnostic Delay

  • Early symptoms may be mistaken for other causes of acute diarrhea such as viral gastroenteritis.

  • Limited access to stool testing can delay outbreak confirmation. Begin rehydration from the clinical assessment immediately.

  • Mild or asymptomatic cases may not seek medical attention, delaying outbreak recognition.

Clinical Presentation


Signs & Symptoms

  • Profuse watery diarrhea described as 'rice-water stools' without blood or pus

  • Severe dehydration symptoms including thirst, weakness, and dizziness

  • Vomiting often accompanies diarrhea

  • Muscle cramps due to electrolyte loss

  • Hypotension and tachycardia from volume depletion

History of Present Illness

  • Abrupt onset of profuse watery diarrhea described as 'rice-water stools' is characteristic.

  • Rapid progression to dehydration with symptoms of thirst, weakness, and muscle cramps occurs.

  • Vomiting often accompanies diarrhea early in the illness.

  • Patients may report exposure to contaminated water or recent travel to endemic areas.

Past Medical History

  • Previous episodes of cholera or other diarrheal illnesses may be noted.

  • History of immunosuppression or malnutrition increases risk of severe disease.

  • Lack of prior cholera vaccination is relevant in endemic regions.

Family History

  • Cholera is an acquired infection. Blood group O is associated with more severe disease among infected people.

  • Family members may share exposure risks due to common water sources or living conditions.

Physical Exam Findings

  • Dehydration signs including dry mucous membranes and decreased skin turgor

  • Hypotension and tachycardia due to volume depletion

  • Sunken eyes and cold extremities indicating severe hypovolemia

  • Delayed capillary refill and cool extremities can indicate poor peripheral perfusion.

  • Muscle cramps from electrolyte imbalances

Diagnostic Workup


Diagnostic Criteria

Suspect cholera with acute watery diarrhea and compatible exposure. Assess dehydration and initiate rehydration immediately. Stool culture with O1/O139 serogrouping or appropriate PCR supports laboratory confirmation. Establish toxigenicity when indicated by the epidemiologic setting. Rapid antigen tests can flag a possible outbreak but require confirmatory testing.

Pathophysiology


Key Mechanisms

  • The B subunits of the AB5 toxin bind GM1 ganglioside on enterocytes. The A1 fragment ADP-ribosylates Gsα, impairing GTP hydrolysis and maintaining the active GTP-bound state. Adenylyl cyclase activity and intracellular cAMP rise.

  • cAMP activates protein kinase A, which increases CFTR-mediated chloride secretion. Water follows electrolytes into the intestinal lumen.

  • The result is secretory diarrhea that persists during fasting. Apical sodium-glucose cotransport through SGLT1 still absorbs sodium with glucose, and water follows.

  • Stool bicarbonate loss causes a normal-anion-gap metabolic acidosis. If hypovolemic shock impairs tissue perfusion, lactic acidosis can add a high-anion-gap component.

InvolvementDetails
Organs

Small intestine is the main organ involved in cholera pathogenesis, where the cholera toxin disrupts electrolyte and water absorption.

Kidneys are critical organs affected secondarily due to dehydration and electrolyte imbalances caused by cholera-induced diarrhea.

Tissues

Intestinal mucosa is the primary tissue affected by Vibrio cholerae infection, where toxin-induced secretion causes profuse diarrhea.

Cells

Enterocytes are the intestinal epithelial cells targeted by cholera toxin, leading to increased chloride secretion and watery diarrhea.

Absorptive enterocytes retain sodium-glucose cotransport during toxin-induced secretion. Glucose and salts supplied together improve net water absorption.

Chemical Mediators

Cholera toxin activates adenylate cyclase in enterocytes, increasing cyclic AMP and causing chloride and water secretion.

cAMP is the key intracellular mediator elevated by cholera toxin that drives secretory diarrhea.

Treatments


Pharmacological Treatments

  • Doxycycline

    • Mechanism:
      • Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Vibrio cholerae.

    • Side effects:
      • Gastrointestinal upset

      • Photosensitivity

      • Dental staining is a concern with older tetracyclines or prolonged exposure during tooth development. It is not a blanket reason to withhold single-dose doxycycline in severe cholera.

    • Clinical role:
      • Adjunct to rehydration for severe cholera and selected high-risk patients. A susceptible strain may be treated with a single dose under local guidance.

  • Azithromycin

    • Mechanism:
      • Macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Vibrio cholerae.

    • Side effects:
      • Gastrointestinal upset

      • QT prolongation

      • Allergic reactions

    • Clinical role:
      • An alternative adjunct for indicated cases when local susceptibility and patient factors support its use. Begin fluid replacement immediately.

  • Tetracycline

    • Mechanism:
      • Bacteriostatic antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit of Vibrio cholerae.

    • Side effects:
      • Photosensitivity

      • Gastrointestinal upset

      • Tooth discoloration in children

    • Clinical role:
      • Tetracycline is an older susceptible-strain option with age- and pregnancy-related precautions. Follow current local guidance for agent selection.

Non-pharmacological Treatments

  • Give correctly prepared oral rehydration solution (ORS) promptly to patients who can drink. Replace ongoing losses and reassess hydration frequently.

  • Severe dehydration or shock requires immediate IV isotonic crystalloid, preferably lactated Ringer solution. Start ORS as soon as the patient can safely drink and continue replacing stool losses.

  • Continue breastfeeding and resume feeding as tolerated. Monitor ongoing stool losses, urine output, electrolytes and glucose when clinically indicated.

Prevention


Pharmacological Prevention

  • Killed oral cholera vaccines are used in endemic and outbreak settings together with safe water, sanitation and hygiene.

  • Mass preventive antibiotic administration during outbreaks is discouraged because it has no proven benefit for spread and can select resistance.

  • Zinc is a treatment adjunct for eligible children with acute diarrhea. It does not replace ORS or serve as routine cholera prophylaxis.

  • No effective chemoprophylaxis for travelers routinely recommended

  • For US travelers aged 2–64 years visiting areas with active transmission, CDC recommends the live oral CVD 103-HgR vaccine. Safe food and water practices remain important.

Non-pharmacological Prevention

  • Access to clean water and improved sanitation to prevent fecal-oral transmission

  • Proper hand hygiene especially after using the toilet and before eating

  • Safe food preparation and storage to avoid contamination

  • Public health measures including surveillance and outbreak control

  • Health education on avoiding contaminated water sources

Outcome & Complications


Complications

  • Hypovolemic shock from rapid fluid loss

  • Acute kidney injury due to severe dehydration

  • Electrolyte imbalances causing cardiac arrhythmias

  • Seizures or altered consciousness warrant checking glucose and sodium, especially in children. Potassium loss can cause muscle weakness and arrhythmias.

  • Death if untreated or in resource-limited settings

Short-term Sequelae Long-term Sequelae
  • Severe dehydration requiring aggressive fluid resuscitation

  • Electrolyte disturbances such as hypokalemia and metabolic acidosis

  • Poor renal perfusion can cause prerenal azotemia. Sustained shock can progress to ischemic tubular injury.

  • Hypotensive shock necessitating urgent management

  • Ongoing stool losses can rapidly reverse an initial improvement in hydration. Cholera typically causes noninvasive small-intestinal secretion.

  • Most patients recover after prompt rehydration. Severe shock may cause ischemic kidney injury requiring follow-up.

  • Repeated diarrheal illness and poor intake can worsen undernutrition in children. Resume age-appropriate feeding and breastfeeding during recovery.

  • Persistent or recurrent diarrhea after recovery warrants evaluation for other causes or a new exposure.

  • Lasting organ injury is chiefly a concern after severe dehydration, shock or another complication.

  • No direct chronic infection or carrier state typically occurs

Differential Diagnoses


Cholera (Vibrio cholerae) versus Enterotoxigenic Escherichia coli (ETEC) infection

Cholera (Vibrio cholerae)

Enterotoxigenic Escherichia coli (ETEC) infection

Comma-shaped, gram-negative rod producing cholera toxin

ETEC produces heat-labile toxin (increases cAMP), heat-stable toxin (increases cGMP), or both.

Contaminated water sources in endemic regions with poor sanitation

Contaminated food or water in travelers to endemic areas

Profuse, watery 'rice-water' diarrhea causing severe dehydration

Mild to moderate watery diarrhea, often self-limited

Confirm by culture and serogrouping or appropriate molecular testing. TCBS colony appearance alone cannot identify a toxigenic strain.

Detection of heat-labile or heat-stable toxin genes by PCR

Cholera (Vibrio cholerae) versus Rotavirus infection

Cholera (Vibrio cholerae)

Rotavirus infection

Cholera occurs at any age. Exposure, prior immunity and physiological reserve affect severity.

Primarily affects infants and young children

Sudden watery diarrhea can be accompanied by vomiting. Fever and bloody stools are atypical.

Fever, vomiting, and watery diarrhea lasting 3-8 days

Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity.

Detection of viral antigen in stool by enzyme immunoassay

Cholera (Vibrio cholerae) versus Shigellosis

Cholera (Vibrio cholerae)

Shigellosis

Non-invasive gram-negative curved rod producing enterotoxin

Gram-negative rod causing invasive colitis

Profuse nonbloody watery stool may contain flecks of mucus, giving a rice-water appearance.

Inflammatory diarrhea can progress to bloody, mucoid stools with fever, cramps or tenesmus.

Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity.

Positive stool culture for Shigella species

Cholera (Vibrio cholerae) versus Giardiasis

Cholera (Vibrio cholerae)

Giardiasis

Gram-negative bacterium producing enterotoxin

Flagellated protozoan parasite

Acute profuse watery diarrhea without malabsorption

Chronic, foul-smelling, fatty diarrhea with malabsorption

Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity.

Stool antigen or nucleic acid tests detect Giardia. Microscopy can identify cysts or trophozoites.

Cholera (Vibrio cholerae) versus Clostridium difficile infection

Cholera (Vibrio cholerae)

Clostridium difficile infection

Exposure to contaminated water or food in endemic areas

Recent antibiotic use or hospitalization

Profuse watery diarrhea without colitis or pseudomembranes

Watery diarrhea with abdominal pain and possible pseudomembranous colitis

Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity.

In a symptomatic patient, NAAT detects toxin genes whereas toxin immunoassay detects toxin protein. A positive NAAT alone can reflect colonization.